Detalhe da pesquisa
1.
Accelerating Rare Disease Drug Development: Lessons Learned from Muscular Dystrophy Patient Advocacy Groups.
Ther Innov Regul Sci;
55(2): 370-377, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32974874